Blood & Marrow Stem Cell Transplantation: Related News

On Our Blog

Pictured: Marcel van den Brink & Robert Jenq
Bacteria May Hold the Key to Preventing Dangerous Side Effect of Transplants

Research suggests that the presence of a type of bacteria called Blautia, which occurs naturally in the body, may prevent graft-versus-host disease, a potentially fatal side effect of bone marrow and stem cell transplants.

March 3, 2014
Pictured: Sergio Giralt
Memorial Sloan Kettering’s Expertise Stands Out at Transplant Meeting

Memorial Sloan Kettering’s leadership in blood and marrow stem cell transplantation is on full display at the 2014 BMT Tandem Meeting.

February 26, 2014
Pictured: Sergio Giralt & Robin Roberts
Robin Roberts Celebrates with Fellow Stem Cell Transplant Recipients

Robin Roberts celebrated with more than 200 fellow stem cell transplant patients at Memorial Sloan Kettering’s annual Stem Cell Transplant Survivors Celebration.

October 17, 2013
New Information about Multiple Myeloma Care at Memorial Sloan Kettering

Memorial Sloan Kettering specialists provide outstanding care for multiple myeloma and related plasma cell diseases.

September 13, 2013
Pictured: Clostridium difficile
Microbiome Studies May Benefit Cancer Patients

Information about the microbiome, the genes of all the microorganisms that naturally inhabit the human body, is leading to new approaches for treating infections in cancer patients.

August 7, 2013
Pictured: Andromachi Scaradavou
How Do I Decide Whether I Should Bank Cord Blood from My Newborn?

In this “Ask the Expert” feature, pediatric hematologist Andromachi Scaradavou discusses options for expectant parents who are considering banking a newborn’s cord blood.

July 24, 2013
Pictured: Robin Roberts & Sergio Giralt
The Bone Marrow Foundation and Good Morning America’s Robin Roberts Honor Memorial Sloan Kettering Transplant Physician Sergio Giralt

Sergio Giralt, Chief of Memorial Sloan Kettering’s Adult Bone Marrow Transplant Service, has been recognized for his achievements in the field of bone marrow transplantation with an award presented by GMA’s Robin Roberts.

June 7, 2013
Pictured: Robin Roberts & Tonya Samuel
Good Morning America’s Robin Roberts Returns to Work after Treatment at Memorial Sloan Kettering

Co-host Robin Roberts gives thanks to her Memorial Sloan Kettering treatment team during her first day returning to the show after receiving a stem cell transplant.

February 20, 2013
Pictured: Marcel R. M. van den Brink
New Treatment May Help Transplant Patients Recover Immune Function More Quickly

Memorial Sloan Kettering researchers have shown for the first time that administering a growth factor called interleukin-7 can help patients regenerate T cells more quickly after stem cell transplantation.

December 21, 2012
Pictured: Robin Roberts
Good Morning America’s Robin Roberts Begins Next Phase of Recovery from a Stem Cell Transplant

Good Morning America co-host Robin Roberts recently said good-bye to her inpatient treatment team at Memorial Sloan Kettering after undergoing a stem cell transplant to treat myelodysplastic syndrome.

October 11, 2012
Pictured:
Two Memorial Sloan Kettering Studies Focus on Role of Antibiotics in Stem Cell Transplantation

Researchers examined how changes in the microbiota may make patients more susceptible to severe infections and other complications.

September 13, 2012
Pictured: Natural Killer Cells & Cancer Cell
Study Suggests Refined Donor Selection Could Improve Outcomes of Bone Marrow Transplantation in Leukemia

In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.

September 4, 2012
Pictured: Adult Bone Marrow Transplantation Team
Stem Cell Transplant Experts Discuss the Procedure and How to Become a Stem Cell Donor

In an interview, experts on our Adult Bone Marrow Transplantation Service talk about the types of transplantation and finding an appropriate donor for an allogeneic transplant.

August 30, 2012
Pictured: Joao Xavier and Eric Pamer
Two Memorial Sloan Kettering Studies Focus on Role of Antibiotics in Stem Cell Transplantation

New studies investigate how the use of antibiotics affects the balance of both harmful and beneficial bacteria in patients undergoing stem cell transplantation.

July 19, 2012
Pictured: T cells on surface on thymus
Study Points the Way for Future Therapy to Revive a Damaged Immune System

A recent study holds promise for the development of a new type of drug to alleviate immune deficiency caused by cancer treatment, radiation injury, or certain diseases.

April 6, 2012
Pictured: Sergio Giralt
Memorial Sloan Kettering’s One-Year Survival Rate after Allogeneic Bone Marrow Transplant Exceeds Expectations

Adult Bone Marrow Transplantation Service Chief Sergio Giralt explains recent advances that are enabling more patients to survive the most difficult period after receiving a transplant.

March 26, 2012
Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
Cell-Based Therapies Show Promise

Years of innovative research, technology development, and facility expansion at Memorial Sloan Kettering have led to several new experimental treatments for people with cancer.

December 28, 2011
Researchers Show Therapy Could Improve Stem Cell Transplants

A Memorial Sloan Kettering study suggests that a new, experimental treatment could make bone marrow and stem cell transplantation safer and more effective.

December 12, 2011
Pictured: Diane Vigar, Steve Hasday & Peter Smith
Stem Cell Transplant Survivors Celebrate

“This is a celebration about your journey to return to the life you want to have,” Adult Bone Marrow Transplant Center Chief Sergio Giralt told 200 survivors at a party packed with friends and caregivers.

December 9, 2011
Cognitive-Behavioral Therapy by Phone for Cancer-Related PTSD

Many survivors of stem cell transplants experience long-term medical and psychological adjustment problems, including symptoms of posttraumatic stress disorder (PTSD). A recent study conducted by investigators from Mount Sinai School of Medicine, Memorial Sloan Kettering Cancer Center, and Hackensack University Medical Center suggests that a course of cognitive behavior therapy — even if conducted by telephone — can help reduce the symptoms of PTSD in such patients.

August 1, 2010
Katharine C. Hsu
Researchers Establish Further Immune Benefit of Blood Stem Cell Transplants

Memorial Sloan Kettering medical oncologist Katharine C. Hsu and colleagues have described an immune benefit of allogeneic, or donor-provided, blood stem cell transplants in patients being treated for leukemia.

May 1, 2009
New Clinic Enhances Adult Bone Marrow Transplant Service

Opened in the spring of 2008, a new outpatient clinic within Memorial Hospital is enabling Memorial Sloan Kettering’s adult allogeneic bone marrow transplant service to enhance comfort and convenience for a rapidly growing patient population.

December 1, 2008

Clinical Updates

Related Media Coverage

ASH 2013 Preview: CAR Modified T Cells, Novel Assays, and Ibrutinib

Hematologic Oncology Division Head Marcel van den Brink comments on abstracts being presented by Memorial Sloan Kettering physicians at the 2013 American Society of Hematology Annual Meeting and Exposition.

December 4, 2013
Robin Roberts: "I'm Stronger Than I Thought I Was"

Hematologist-oncologist Sergio Giralt was interviewed about treating Good Morning America co-host Robin Roberts, who received a stem cell transplant at Memorial Sloan Kettering.

March 31, 2013
Sergio Giralt
Sergio Giralt Named Chief of the Adult Bone Marrow Transplantation Service at Memorial Sloan Kettering

Sergio Giralt, MD, has been appointed Chief of the Adult Bone Marrow Transplantation Service in the Division of Hematologic Oncology in the Department of Medicine at Memorial Sloan Kettering Cancer Center.

June 1, 2010